Investor Wynnefield Partners Small Cap Value Lp I
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Wynnefield Partners Small Cap Value Lp I . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-12-23 13D/A 433,605 433,605
2024-07-30 13D/A TPCS / TechPrecision Corporation 433,605 433,605
2024-07-05 13D/A LFCR / Lifecore Biomedical, Inc. 5,007,666 5,007,666
2024-07-02 13D/A LFCR / Lifecore Biomedical, Inc. 4,926,795 5,007,666
2024-07-02 13D TPCS / TechPrecision Corporation 433,605
2023-03-16 13D/A LFCR / Lifecore Biomedical, Inc. 4,462,510 4,926,795
2023-02-16 13G SANW / S&W Seed Company 4,112,950
2022-12-02 13D/A LFCR / Lifecore Biomedical, Inc. 3,577,705 4,462,510
2022-03-22 13D/A SUMR / Summer Infant Inc 6,829,086 784,183
2022-01-20 13D/A LNDC / Landec Corp. 3,190,305 3,577,705
2021-04-20 13D/A LNDC / Landec Corp. 2,682,400 3,190,305
2020-11-03 13D/A MSLP / MusclePharm Corp 2,011,874 2,111,874
2020-10-28 13D/A MSLP / MusclePharm Corp 2,011,905 2,011,874
2020-08-14 13D/A US5538291023 / MVC Capital, Inc. 1,514,379 1,559,270
2020-07-13 13D/A MSLP / MusclePharm Corp 1,931,305 2,011,905
2020-06-01 13D/A US5538291023 / MVC Capital, Inc. 1,514,379 1,514,379
2020-04-27 13D/A US5538291023 / MVC Capital, Inc. 1,514,379 1,514,379
2020-04-21 13D/A US5538291023 / MVC Capital, Inc. 1,514,379 1,514,379
2020-01-22 13D/A US5538291023 / MVC Capital, Inc. 1,600,000 1,514,379
2019-08-22 13D/A MSLP / MusclePharm Corp 1,883,513 1,931,305
2019-03-12 13D/A SUMR / Summer Infant Inc 6,653,932 6,829,086
2019-03-12 13D/A MSLP / MusclePharm Corp 1,643,305 1,883,513
2018-07-25 13D/A MSLP / MusclePharm Corp 14,731,667 1,643,305
2018-07-24 13D/A MSLP / MusclePharm Corp 1,336,305 14,731,667
2018-06-27 13D/A XRM / Xerium Technologies, Inc. 1,214,540 1,214,540
2018-05-29 13D/A XRM / Xerium Technologies, Inc. 1,152,250 1,214,540
2018-05-24 13D/A LNDC / Landec Corp. 2,682,400
2018-05-11 13D/A SUMR / Summer Infant Inc 5,673,394 6,653,932
2018-04-09 13D/A GLYE / GlyEco Inc 49,797,748 54,797,748
2018-01-03 13D/A MSLP / MusclePharm Corp 1,636,305 1,336,305
2017-11-01 13D/A MSLP / MusclePharm Corp 1,631,305 1,636,305
2017-08-18 13D/A GLYE / GlyEco Inc 32,922,748 49,797,748
2017-07-10 13D/A MSLP / MusclePharm Corp 1,187,470 1,631,305
2017-06-28 13D/A XRM / Xerium Technologies, Inc. 947,100 1,152,250
2017-06-12 13D NATR / Nature's Sunshine Products, Inc. 2,184,329
2017-05-30 13D/A LTRE / Learning Tree International, Inc. 715,000 907,684
2017-05-17 13D/A GLYE / GlyEco Inc 32,922,748 32,922,748
2017-05-03 13D XRM / Xerium Technologies, Inc. 947,100
2017-01-06 13D/A GLYE / GlyEco Inc 29,485,247 32,922,748
2016-11-29 13D/A SUMR / Summer Infant Inc 5,193,486 5,673,394
2016-11-22 13D/A SUMR / Summer Infant Inc 4,538,406 5,193,486
2016-11-22 13D/A MSLP / MusclePharm Corp 1,150,470 1,187,470
2016-09-15 13D/A MSLP / MusclePharm Corp 920,415 1,150,470
2016-08-24 13D/A SUMR / Summer Infant Inc 4,334,672 4,538,406
2016-08-12 13D/A SUMR / Summer Infant Inc 4,098,606 4,334,672
2016-06-01 13D US5538291023 / MVC Capital, Inc. 1,600,000
2016-06-01 13D US5538291023 / MVC Capital, Inc. 1,600,000
2016-04-28 13D/A OME / Omega Protein Corp. 1,713,051 1,752,636
2016-03-30 13D/A OME / Omega Protein Corp. 1,490,494 1,713,051
2016-03-09 13D/A GLYE / GlyEco Inc 10,635,247 29,485,247
2016-03-01 13D/A OME / Omega Protein Corp. 1,687,917 1,490,494
2015-12-22 13D/A SUMR / Summer Infant Inc 3,878,645 4,098,606
2015-12-17 13D/A HAMP / Hampshire Group, Ltd. 1,182,463
2015-11-17 13D/A OME / Omega Protein Corp. 1,687,917 1,687,917
2015-11-16 13D/A SUMR / Summer Infant Inc 3,878,645
2015-11-09 13D/A MSLP / MusclePharm Corp 690,000 920,415
2015-10-08 13D/A OME / Omega Protein Corp. 1,642,400 1,687,917
2015-09-10 13G/A WLMS / Williams Industrial Services Group Inc 2,413,146 2,675,326
2015-08-11 13D OME / Omega Protein Corp. 1,642,400
2015-08-10 13G WLMS / Williams Industrial Services Group Inc 2,413,146
2015-07-20 13D LTRE / Learning Tree International, Inc. 715,000
2015-07-01 13D MSLP / MusclePharm Corp 640,000 690,000
2015-06-24 13D/A MSLP / MusclePharm Corp 1,040,000 640,000
2015-06-09 13D/A MSLP / MusclePharm Corp 1,040,000 1,040,000
2015-05-12 13D/A US8326822074 / SMTC Corp. 1,392,832
2015-04-20 13D MSLP / MusclePharm Corp 1,040,000
2015-04-16 13D/A GLYE / GlyEco Inc 10,635,247
2015-02-25 13D/A GLYE / GlyEco Inc 10,635,247
2014-12-08 13D/A US8326822074 / SMTC Corp. 1,149,631
2014-11-18 13D/A GLYE / GlyEco Inc 4,481,399
2014-11-17 13D/A SUMR / Summer Infant Inc 3,405,200
2014-10-17 13D/A LNDC / Landec Corp. 2,650,000
2014-03-28 13D/A GLYE / GlyEco Inc 4,481,399
2014-03-13 13D/A GLYE / GlyEco Inc 4,091,989
2014-01-24 13D/A GLYE / GlyEco Inc 3,375,000
2013-10-15 13D GLYE / GlyEco Inc 3,375,000
2013-08-20 13D US8326822074 / SMTC Corp. 860,750
2013-06-14 13D/A SUMR / Summer Infant Inc 3,025,000
2013-04-18 13D/A 001930205 / ARI Network Services, Inc. 1,200,000
2012-11-29 13D/A HAMP / Hampshire Group, Ltd. 705,934
2012-11-15 13D SUMR / Summer Infant Inc 3,000,000
2012-11-14 13D HAMP / Hampshire Group, Ltd. 655,984
2012-10-02 13D/A LNDC / Landec Corp. 2,193,271
2012-06-14 13D LNDC / Landec Corp. 2,568,271